Demand for a Lyme vaccine should be greater than ever before. When LYMErix first hit the market in 1998, the number of reported cases was about 17,000. By 2017, that number had climbed to roughly 40,000. And CDC estimates that far more — some 300,000 people — are actually diagnosed each year.
↧